CAS 1186426-66-3
:Formel:C16H25FN4O2
InChl:InChI=1S/C16H25FN4O2/c1-16(2,8-14(22)20-5-3-4-6-20)19-10-15(23)21-11-12(17)7-13(21)9-18/h12-13,19H,3-8,10-11H2,1-2H3/t12-,13-/m0/s1
InChI Key:VQKSCYBKUIDZEI-STQMWFEESA-N
SMILES:CC(C)(CC(=O)N1CCCC1)NCC(=O)N2C[C@H](C[C@H]2C#N)F
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
8 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
DBPR108
CAS:DBPR108 is an orally bioavailable dipeptide-derived DPP4 inhibitor (IC50: 15 nM) and it has no inhibition on DDP8 and DPP9.Formel:C16H25FN4O2Reinheit:99.68%Farbe und Form:SolidMolekulargewicht:324.3937(2S,4S)-4-Fluoro-1-((2-Methyl-4-Oxo-4-(Pyrrolidin-1-Yl)Butan-2-Yl)Glycyl)Pyrrolidine-2-Carbonitrile
CAS:(2S,4S)-4-Fluoro-1-((2-Methyl-4-Oxo-4-(Pyrrolidin-1-Yl)Butan-2-Yl)Glycyl)Pyrrolidine-2-CarbonitrileFormel:C16H25FN4O2Reinheit:>98%Molekulargewicht:324.39(2S,4S)-4-Fluoro-1-((2-methyl-4-oxo-4-(pyrrolidin-1-yl)butan-2-yl)glycyl)pyrrolidine-2-carbonitrile
CAS:Formel:C16H25FN4O2Reinheit:%Farbe und Form:SolidMolekulargewicht:324.3937DBPR108
CAS:(2S,4S)-4-Fluoro-1-((2-methyl-4-oxo-4-(pyrrolidin-1-yl)butan-2-yl)glycyl)pyrrolidine-2-carbonitrileFormel:C16H25FN4O2Reinheit:98+%Molekulargewicht:324.39DBPR108
CAS:DPP-4 is an enzyme that inactivates the incretin hormone glucagon-like peptide-1 (GLP-1). DBPR108 is a small molecule inhibitor of DPP-4. DPP-4 inhibitors have been shown to be effective in clinical trials for type 2 diabetes, with improvements in glycaemic control and weight management. This drug has a long half life and is orally active, with a high level of protein binding. It is also chemically stable, even at high temperatures or pH levels, which means it can be used as an inhibitor drug in the treatment of other diseases.
Formel:C16H25FN4O2Reinheit:Min. 95%Molekulargewicht:324.39 g/mol
